NCT07259317 2026-02-20Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaCorcept TherapeuticsPhase 2 Recruiting60 enrolled
NCT01839487 2020-07-20PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerHalozyme TherapeuticsPhase 2 Completed279 enrolled 19 charts